Volume-regulated anion channel (VRAC) (VRAC)

The Volume-regulated anion channel (VRAC), also known as the swelling-activated chloride channel, is a critical transmembrane protein complex responsible for maintaining cellular volume homeostasis (Voss et al., 2014, Science). It is composed of heteromers from the Leucine-rich repeat-containing protein 8 (LRRC8) family, with LRRC8A being the essential pore-forming subunit (Qiu et al., 2014, Cell). VRAC is activated in response to hypotonic stress, allowing the efflux of chloride ions and organic osmolytes such as taurine and glutamate, which facilitates water exit and regulatory volume decrease (Planells-Cases et al., 2015, Nat Rev Mol Cell Biol). In addition to volume regulation, VRAC is involved in diverse physiological processes including apoptosis, cell proliferation, and insulin signaling (Osei-Owusu et al., 2018, Front Pharmacol). Pathologically, VRAC contributes to glutamate-mediated excitotoxicity during ischemic stroke and plays a significant role in cancer, where its expression levels influence sensitivity to platinum-based chemotherapy (Zhang et al., 2017, JCI Insight). Current pharmacological strategies focus on small-molecule inhibitors like DCPIB and tamoxifen, although the development of subunit-specific modulators is an active area of research to improve therapeutic selectivity. The channel's ability to transport diverse molecules, including antibiotics and anticancer drugs, makes it a significant factor in drug pharmacokinetics and resistance. Targeting VRAC offers potential for treating conditions ranging from stroke to metabolic disorders, provided that off-target effects in healthy tissues can be minimized.

Other names

Swelling-activated chloride channelVolume-sensitive outward-rectifier chloride channelVSORVolume-sensitive organic anion channelVSOACLRRC8 complexI(Cl,swell)

Inhibition of the anion-conducting pore to prevent chloride and osmolyte efflux, or modulation of subunit composition to alter substrate specificity.